ICJIM
Intercontinental Journal of Internal Medicine

The Intercontinental Journal of Internal Medicine aims to publish issues related to all fields of internal medicine of the highest scientific and clinical value at an international level and accepts articles on these topics. This journal is indexed by indices that are considered international scientific journal indices (DRJI, ESJI, OAJI, etc.). According to the current Associate Professorship criteria, it is within the scope of International Article 1-d. Each article published in this journal corresponds to 5 points.

eISSN: 2980-0846
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Original Article
Bone density in patients with nonfunctional adrenal incidentaloma
Abstract
Aims: Adrenal incidentalomas (AI) are adrenal masses that are detected incidentally in imaging studies performed for different reasons in people who do not have any complaints suggestive of adrenal gland disease. The overall prevalence, approximately just over 4%, increases with age. AI is detected in approximately 10% of people over the age of 70. In this context, we thought that CT imaging, which is already used in the diagnosis and follow-up of AI, can contribute to the evaluation of muscle and bone mass without creating additional costs.
Methods: In this retrospective study, 39 patients who were followed up with NFAI by the endocrinology department and 30 healthy individuals with normal adrenal imaging in the abdominal CT examination as the control group were included. Patients with chronic diseases or drug use that may affect bone and muscle mass, and individuals in the postmenopausal period were excluded in this study. Endocrine tests performed to exclude autonomous cortisol secretion, pheochromocytoma and primary hyperaldosteronism; VMA and fractionated metanephrines in 24-hour urine, cortisol values after 1 mg dexamethasone suppression test, baseline serum dehydroepiandrosterone sulfate (DHEAS) levels and plasma aldosterone (ng/dl)/renin (ng/ml/hour) ratio were measured. Autonomous cortisol production was excluded in patients with serum cortisol below 1.8 mcg/dl after 1 mg dexamethasone suppression.
Results: 39 patients with NFAI and 30 healthy volunteers participated in the study. In the NFAI group, 69.2% (n= 27) were female and 30.8% (n=12) were male. In the healthy control group 63.3% (n=19) of the people were female and 37.7% (n=11) were male. There was no statistically significant difference between the two groups in terms of gender (p=061). The mean age of the NFAI group is 43 and the mean age of the control group is 49, and there was no statistically significant difference in age between the two groups (p=0.06)
Conclusion: No decrease was found in BMD and paravertebral muscle mass values in the measurements made at L1-3 vertebral level with CT in NAFI patients. Further studies are needed in a larger patient population where the results are evaluated together with the femur and vertebral BMD measurements by DXA method, and muscle strength and performance are evaluated in addition to muscle mass in terms of sarcopenia.

Keywords : Adrenal incidentaloma, bone-mineral density, nonfunctional adrenal incidentalomas, NFAI

Download Article


1. Kelsall A, Iqbal A, Newell-Price J. Adrenal incidentaloma:cardiovascular and metabolic effects of mild cortisol excess. GlandSurgery. 2020;9(1):94.
2. Komarowska H, Brominska B, Janicka-Jedynska M, Ruchala M.Adrenal incidentaloma: nothing is ever as it seems. Am J Med.2020;133(9):1048-1050.
3. Reimondo G, Muller A, Ingargiola E, Puglisi S, Terzolo M. Is follow-up of adrenal incidentalomas always mandatory? Endocrinol Metab.2020;35(1):26-35.
4. Akkuş O, Akkuş G, Kaypaklı O, et al. Increased rates of coronary arterycalcium score in patients with non-functioning adrenal incidentaloma.Endocrine Metab Immune Disord Drug Targ (Formerly Current DrugTargets-Immune, Endocrine & Metabolic Disorders). 2021;21(7):1319-1325.
5. Akkuş G, Evran M, Sert M, Tetiker T. Adipocytokines in non-functional adrenal incidentalomas and relation with insulin resistanceparameters. Endocrine Metab Immune Disord Drug Targ (FormerlyCurrent Drug Targets-Immune, Endocrine & Metabolic Disorders).2019:19(3):326-332.
6. Kim BJ, Kwak MK, Ahn SH, Kim JS, Lee SH, Koh JM. The associationof cortisol and adrenal androgen with trabecular bone score in patientswith adrenal incidentaloma with and without autonomous cortisolsecretion. Osteoporosis Int. 2018;29(10):2299-2307.
7. Altieri B, Muscogiuri G, Paschou SA, et al. Adrenocorticalincidentalomas and bone: from molecular insights to clinicalperspectives. Endocrine. 2018;62(3):506-516.
8. Morelli V, Donadio F, Eller-Vainicher C. Role of glucocorticoidreceptor polymorphism in adrenal incidentalomas. Eur J Clin Invest.2010;40(9):803-811.
9. Cooper MS, Rabbitt EH, Goddard PE, Bartlett WA, Hewison M,Stewart PM. Osteoblastic 11beta-hydroxysteroid dehydrogenase type 1activity increases with age and glucocorticoid exposure. J Bone MinerRes. 2002;17(6): 979-986.
10. Ognjanovic S, Antic J, Pekmezovic T, et al. The association ofglucocorticoid receptor polymorphism with metabolic outcomesin menopausal women with adrenal incidentalomas. Maturitas.2021;151:15-21.
11. Vinolas H, Grouthier V, Mehsen-Cetre N, et al. Assessment of vertebralmicroarchitecture in overt and mild Cushing’s syndrome usingtrabecular bone score. Clin Endocrin.2018;89(2):148-154.
12. Hong SH, Choi KM. Sarcopenic obesity, insulin resistance, and theirimplications in cardiovascular and metabolic consequences. Int J MolSci. 2020;21(2):494.
13. Wong SK, Chin KY, Suhaimi FH, Ahmad F, Ima-Nirwana S. Therelationship between metabolic syndrome and osteoporosis: a review.Nutrients. 2016;8(6):347.
14. Wong SK, Chin KY, Suhaimi FH, Ahmad F, Jamil NA, Ima-Nirwana S.Osteoporosis is associated with metabolic syndrome induced by high-carbohydrate high-fat diet in a rat model. Biomed & Pharmacother.2018;98:191-200.
15. Lin HH, Huang CY, Hwang LC. Association between metabolicsyndrome and osteoporosis in Taiwanese middle-aged and elderlyparticipants. Archi Osteop. 2018;13(1):1-7.
16. Kim JH, Kwak MK, Ahn SH, et al. Alteration in skeletal muscle mass inwomen with subclinical hypercortisolism. Endocrine. 2018;61:134-143.
17. Kwak MK, Lee SE, Cho YY, et al. The differential effect ofexcess aldosterone on skeletal muscle mass by sex. FrontEndocrino.2019;10:195.
18. Moraes AB, Cavalari EMR, de Paula MP, et al. Evaluation of bodycomposition using dual-energy X-ray absorptiometry in patientswith non-functioning adrenal incidentalomas and an intermediatephenotype: is there an association with metabolic syndrome? JEndocrinol Invest. 2019;42(7):797-807.
Article available in :
Volume 1, Issue 4, 2023
Page : 80-84
https://doi.org/10.51271/ICJIM-0018
Article Information
Received : 13 Kas 2023
Accepted : 25 Kas 2023
Published : 29 Kas 2023
Corresponding Author :

Turgut Kültür: Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Kırıkkale University, Kırıkkale, Turkiye

[email protected]
Citation : Kültür T, Güngüneş A, Durmaz Ceylan Ş, karatlı S, İnal M, Göncüoğlu A. Bone density in patients with nonfunctional adrenal incidentaloma. Intercont J Int Med 2023;1(4):80-84.

Read: 214
Cited: 0
Download : 166
_Footer